INS and Insulin resistance: This reduction in liver 11β-HSD1 may account for partial impairment of the insulin signaling pathway in the liver in the present study, once overexpression of 11β -HSD1 in the liver in mice results in insulin resistance (Masuzaki et al., 2001; Paterson et al., 2004).